{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:42:08Z","timestamp":1784202128389,"version":"3.55.0"},"reference-count":45,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.1248\/bpb.b26-00003","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:10:06Z","timestamp":1776118206000},"page":"708-719","source":"Crossref","is-referenced-by-count":1,"title":["Localized Rectal Dextran Sulfate Sodium-Induced Colitis Is Associated with Small-Intestinal Shortening and Gut\u2013Liver Axis-Related Alterations"],"prefix":"10.1248","volume":"49","author":[{"given":"Masahiko","family":"Mori","sequence":"first","affiliation":[{"name":"Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Ise","sequence":"additional","affiliation":[{"name":"Histopathology Core Facility, Technical Office, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Hracs L, Windsor JW, Gorospe J, <i>et al<\/i>. Global evolution of inflammatory bowel disease across epidemiologic stages. <i>Nature<\/i>, <b>642<\/b>, 458\u2013466 (2025)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. <i>Nat. Rev. Dis. Primers<\/i>, <b>6<\/b>, 74 (2020).","DOI":"10.1038\/s41572-020-0205-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. <i>Lancet<\/i>, <b>389<\/b>, 1756\u20131770 (2017).","DOI":"10.1016\/S0140-6736(16)32126-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. <i>United European Gastroenterol. J.<\/i>, <b>10<\/b>, 1063\u20131076 (2022).","DOI":"10.1002\/ueg2.12350"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Yamazaki M, Chung H, Xu Y, Qiu H. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US. <i>Int. J. Colorectal Dis.<\/i>, <b>38<\/b>, 135 (2023).","DOI":"10.1007\/s00384-023-04417-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. <i>Yonsei Med. J.<\/i>, <b>62<\/b>, 99\u2013108 (2021).","DOI":"10.3349\/ymj.2021.62.2.99"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. <i>Gut<\/i>, <b>55<\/b>, 749\u2013753 (2006).","DOI":"10.1136\/gut.2005.082909"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sun Y, Ruan G, Guo M, Wei Y, Bai X, Han W, Tan B, Li J, Li Y, Yang H, Qian J. Progressing or preserving, disease extent evolution in hospitalized patients with ulcerative colitis in China: a real-world study. <i>Therap. Adv. Gastroenterol.<\/i>, <b>18<\/b>, 17562848251339878 (2025).","DOI":"10.1177\/17562848251339878"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Murphy ME, Bhattacharya S, Axelrad JE. Diagnosis and monitoring of ulcerative colitis. <i>Clin. Colon Rectal Surg.<\/i>, <b>35<\/b>, 421\u2013427 (2022).","DOI":"10.1055\/s-0042-1758047"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) B\u00fcning C, Geissler N, Prager M, Sturm A, Baumgart DC, B\u00fcttner J, B\u00fchner S, Haas V, Lochs H. Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease? <i>Inflamm. Bowel Dis.<\/i>, <b>18<\/b>, 1932\u20131939 (2012).","DOI":"10.1002\/ibd.22909"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chang J, Leong RW, Wasinger VC, Ip M, Yang M, Phan TG. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. <i>Gastroenterology<\/i>, <b>153<\/b>, 723\u2013731.e1 (2017).","DOI":"10.1053\/j.gastro.2017.05.056"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) He Q, Wei W, Li J, Chen Z, Zhang H. Ulcerative colitis-associated diffuse enteritis without prior colectomy: A case report. <i>Medicine<\/i>, <b>104<\/b>, e42924 (2025).","DOI":"10.1097\/MD.0000000000042924"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kumagai M, Ishii M, Morimoto K, Tomita M. Increased membrane permeation and blood concentration of 6-carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats. <i>Biopharm. Drug Dispos.<\/i>, <b>41<\/b>, 91\u2013100 (2020).","DOI":"10.1002\/bdd.2220"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. <i>Curr. Protoc. Immunol.<\/i>, <b>104<\/b>, 15.25.1\u201315.25.14 (2014).","DOI":"10.1002\/0471142735.im1525s104"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kwon J, Lee C, Heo S, Kim B, Hyun CK. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. <i>Sci. Rep.<\/i>, <b>11<\/b>, 5283 (2021).","DOI":"10.1038\/s41598-021-84761-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Cui M, Yang WM, Yao P. Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats. <i>Sci. Rep.<\/i>, <b>15<\/b>, 2760 (2025).","DOI":"10.1038\/s41598-025-86823-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kawauchi S, Nakamura T, Miki I, Inoue J, Hamaguchi T, Tanahashi T, Mizuno S. Downregulation of CYP3A and P-glycoprotein in the secondary inflammatory response of mice with dextran sulfate sodium-induced colitis and its contribution to cyclosporine A blood concentrations. <i>J. Pharmacol. Sci.<\/i>, <b>124<\/b>, 180\u2013191 (2014).","DOI":"10.1254\/jphs.13141FP"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) McGrosky A, Codron D, M\u00fcller DW, Navarrete A, Isler K, Hofmann RR, Clauss M. Gross intestinal morphometry and allometry in ruminants. <i>J. Morphol.<\/i>, <b>280<\/b>, 1254\u20131266 (2019).","DOI":"10.1002\/jmor.21028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Duque-Correa MJ, Codron D, Meloro C, McGrosky A, Schiffmann C, Edwards MS, Clauss M. Mammalian intestinal allometry, phylogeny, trophic level and climate. <i>Proc. Biol. Sci.<\/i>, <b>288<\/b>, 20202888 (2021).","DOI":"10.1098\/rspb.2020.2888"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Le Naour J, Mont\u00e9gut L, Joseph A, Garbin K, Vacchelli E, Kroemer G, Pol JG, Maiuri MC. Improved Swiss-rolling method for histological analyses of colon tissue. <i>MethodsX<\/i>, <b>9<\/b>, 101630 (2022).","DOI":"10.1016\/j.mex.2022.101630"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pe\u00f1a AS, Meuwissen SGM, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. <i>Clin. Exp. Immunol.<\/i>, <b>114<\/b>, 385\u2013391 (2001).","DOI":"10.1046\/j.1365-2249.1998.00728.x"},{"key":"22","unstructured":"22) Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, K\u00fchl AA. A guide to histomorphological evaluation of intestinal inflammation in mouse models. <i>Int. J. Clin. Exp. Pathol.<\/i>, <b>7<\/b>, 4557\u20134576 (2014)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Catana CS, Magda\u015f C, Tabaran FA, Cr\u0103ciun EC, Deak G, Magda\u015f VA, Cozma V, Gherman CM, Berindan-Neagoe I, Dumitra\u015fcu DL. Comparison of two models of inflammatory bowel disease in rats. <i>Adv. Clin. Exp. Med.<\/i>, <b>27<\/b>, 599\u2013607 (2018).","DOI":"10.17219\/acem\/69134"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DL, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. <i>Nat. Methods<\/i>, <b>9<\/b>, 676\u2013682 (2012).","DOI":"10.1038\/nmeth.2019"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW. ImageJ2: ImageJ for the next generation of scientific image data. <i>BMC Bioinformatics<\/i>, <b>18<\/b>, 529 (2017).","DOI":"10.1186\/s12859-017-1934-z"},{"key":"26","unstructured":"26) Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. <i>Anal. Quant. Cytol. Histol.<\/i>, <b>23<\/b>, 291\u2013299 (2001)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kawai S, Takagi Y, Kaneko S, Kurosawa T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. <i>Exp. Anim.<\/i>, <b>60<\/b>, 481\u2013487 (2011).","DOI":"10.1538\/expanim.60.481"},{"key":"28","unstructured":"28) Nishida T, Katayama K, Horie T, Koyama Y, Nakashima E. Pharmacokinetic study of indocyanine green in rats and its application to the evaluation of hepatic function. <i>Jpn. J. Pharmacol.<\/i>, <b>37<\/b>, 385\u2013392 (1985)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. <i>J. Nucl. Med.<\/i>, <b>52<\/b>, 294\u2013302 (2011).","DOI":"10.2967\/jnumed.110.078360"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ye Z-N, Liu X-T, Gu Y-M, Mao S-X, Liang D-H, Zhan K, Lei H-Q, Huang S-G. Risk factors for non-responsiveness to 5-aminosalicylic acid in patients with ulcerative colitis identified using retrospective clinical study and Mendelian randomization. <i>Sci. Rep.<\/i>, <b>15<\/b>, 9182 (2025).","DOI":"10.1038\/s41598-025-89620-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Maeda Y, Goto Y, Ohnishi F, Koga S, Kawano S, Hieda Y, Goromaru T, Murakami T. 5-Aminosalicylic acid distribution into the intestinal membrane along the gastrointestinal tract after oral administration in rats. <i>Pharmaceutics<\/i>, <b>16<\/b>, 1567 (2024).","DOI":"10.3390\/pharmaceutics16121567"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yazbeck R, Howarth GS, Butler RN, Geier MS, Abbott CA. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis. <i>J. Cell. Physiol.<\/i>, <b>226<\/b>, 3219\u20133224 (2011).","DOI":"10.1002\/jcp.22682"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Mija\u010d DD, Jankovi\u0107 GL, Jorga J, Krsti\u0107 MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. <i>Eur. J. Intern. Med.<\/i>, <b>21<\/b>, 315\u2013319 (2010).","DOI":"10.1016\/j.ejim.2010.04.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Pulley J, Todd A, Flatley C, Begun J. Malnutrition and quality of life among adult inflammatory bowel disease patients. <i>JGH Open<\/i>, <b>4<\/b>, 454\u2013460 (2020).","DOI":"10.1002\/jgh3.12278"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Akiho H, Ihara E, Motomura Y, Nakamura K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. <i>World J. Gastrointest. Pathophysiol.<\/i>, <b>2<\/b>, 72\u201381 (2011).","DOI":"10.4291\/wjgp.v2.i5.72"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Mawe GM. Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. <i>J. Clin. Invest.<\/i>, <b>125<\/b>, 949\u2013955 (2015).","DOI":"10.1172\/JCI76306"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Miller C, Emmanuel A, Zarate-Lopez N, Taylor S, Bloom S. Constipation in ulcerative colitis: pathophysiology and practical management. <i>Frontline Gastroenterol.<\/i>, <b>12<\/b>, 493\u2013499 (2021).","DOI":"10.1136\/flgastro-2020-101566"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kuwahara A, Matsuda K, Kuwahara Y, Asano S, Inui T, Marunaka Y. Microbiota-gut\u2013brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system. <i>Biomed. Res.<\/i>, <b>41<\/b>, 199\u2013216 (2020).","DOI":"10.2220\/biomedres.41.199"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. <i>Nat. Rev. Gastroenterol. Hepatol.<\/i>, <b>15<\/b>, 397\u2013411 (2018).","DOI":"10.1038\/s41575-018-0011-z"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Liu Y, Yang H, Yang S, Qiu L, Fan Y, Liu Z. Mechanism of ulcerative colitis-aggravated liver fibrosis: the activation of hepatic stellate cells and TLR4 signaling through gut-liver axis. <i>Front. Physiol.<\/i>, <b>12<\/b>, 695019 (2021).","DOI":"10.3389\/fphys.2021.695019"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Fitzpatrick LR, Jenabzadeh P. IBD and bile acid absorption: focus on pre-clinical and clinical observations. <i>Front. Physiol.<\/i>, <b>11<\/b>, 564 (2020).","DOI":"10.3389\/fphys.2020.00564"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. <i>J. Lipid Res.<\/i>, <b>56<\/b>, 1085\u20131099 (2015).","DOI":"10.1194\/jlr.R054114"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Halilbasic E, Claudel T, Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. <i>J. Hepatol.<\/i>, <b>58<\/b>, 155\u2013168 (2013).","DOI":"10.1016\/j.jhep.2012.08.002"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kim YS, Hurley EH, Park Y, Ko S. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis. <i>Exp. Mol. Med.<\/i>, <b>55<\/b>, 1380\u20131387 (2023).","DOI":"10.1038\/s12276-023-01042-9"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Hov JR, Karlsen TH. The microbiota and the gut-liver axis in primary sclerosing cholangitis. <i>Nat. Rev. Gastroenterol. Hepatol.<\/i>, <b>20<\/b>, 135\u2013154 (2023).","DOI":"10.1038\/s41575-022-00690-y"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b26-00003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:04:01Z","timestamp":1776485041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b26-00003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00003","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"b26-00003"}}